Apogee Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
23 Aug 24 | SellUS$289,560 | Jane Pritchett Henderson | Individual | 6,000 | US$48.26 |
Insider Trading Volume
Insider Buying: APGE insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,250,790 | 1.8% |
Private Companies | 4,199,437 | 6.05% |
Hedge Funds | 4,762,558 | 6.86% |
VC/PE Firms | 15,236,642 | 21.9% |
Institutions | 43,998,592 | 63.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,236,642 | US$879.3m | 0% | 35.97% | |||
7,505,832 | US$433.2m | 11.3% | 0.03% | |||
4,762,558 | US$274.8m | 0% | 19.53% | |||
3,546,949 | US$204.7m | 56.3% | 0.03% | |||
2,742,549 | US$158.3m | -2.39% | no data | |||
2,712,096 | US$156.5m | 9.91% | 2.31% | |||
2,392,042 | US$138.0m | 29.8% | 6.37% | |||
2,259,073 | US$130.4m | 0% | no data | |||
2,117,870 | US$122.2m | 2.62% | 0.77% | |||
2,105,636 | US$121.5m | 2.2% | 2.67% | |||
1,970,320 | US$113.7m | 5.44% | no data | |||
1,961,863 | US$113.2m | -0.81% | 1.27% | |||
1,940,364 | US$112.0m | 0% | no data | |||
1,561,362 | US$90.1m | 15.9% | no data | |||
1,132,270 | US$65.3m | 52% | 0.02% | |||
1,005,470 | US$58.0m | -2.04% | 0.02% | |||
1,000,000 | US$57.7m | -57% | 1.52% | |||
836,283 | US$48.3m | 41.2% | 7.73% | |||
821,763 | US$47.4m | 34.8% | no data | |||
768,221 | US$44.3m | -34.4% | no data | |||
746,159 | US$43.1m | 6.23% | 0.4% | |||
740,861 | US$42.8m | -2.65% | no data | |||
487,000 | US$28.1m | 26.5% | 1.1% | |||
436,146 | US$25.2m | -10.5% | 0.06% | |||
379,130 | US$21.9m | -47.3% | 0.3% |